David P Schenkein Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David P Schenkein.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David P Schenkein. David P Schenkein is in bluebird bio, Inc. ($BLUE) and Director in bluebird bio, Inc. ($BLUE) and Chief Executive Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in Foundation Medicine, Inc. ($FMI) and Director in Denali Therapeutics Inc. ($DNLI).
Latest Insider Trading Transactions of David P Schenkein
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, BLUE, DNLI, FMI
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 1,686 | 0 | 0 | |
Jun 02 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 1,686 | 0 | 114,277 | 112.6 K to 114.3 K (+1.50 %) |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 2,774 | 0 | 2,775 | |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 0.00 | 821 | 0 | 112,591 | 113.4 K to 112.6 K (-0.72 %) |
Feb 24 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 2,774 | 0 | 113,412 | 110.6 K to 113.4 K (+2.51 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 8,125 | 0 | 0 | |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 0.00 | 2,540 | 0 | 110,638 | 113.2 K to 110.6 K (-2.24 %) |
Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 8,125 | 0 | 113,178 | 105.1 K to 113.2 K (+7.73 %) |
Dec 23 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 90.01 | 5,000 | 450,027 | 26,232 | 31.2 K to 26.2 K (-16.01 %) |
Dec 23 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 90.06 | 25,000 | 2,251,555 | 0 | 25 K to 0 (-100.00 %) |
Dec 23 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 90.01 | 5,000 | 450,027 | 26,232 | 31.2 K to 26.2 K (-16.01 %) |
Dec 23 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 90.06 | 25,000 | 2,251,555 | 0 | 25 K to 0 (-100.00 %) |
Nov 13 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 70.05 | 30,000 | 2,101,590 | 25,000 | 55 K to 25 K (-54.55 %) |
Nov 12 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 60.03 | 10,000 | 600,310 | 55,000 | 65 K to 55 K (-15.38 %) |
Nov 06 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Sell | S | 50.18 | 10,000 | 501,830 | 65,000 | 75 K to 65 K (-13.33 %) |
Jun 22 2020 | BLUE | bluebird bio, Inc. | Schenkein David P | Option Exercise | A | 64.09 | 3,000 | 192,270 | 3,000 | ||
Jun 22 2020 | BLUE | bluebird bio, Inc. | Schenkein David P | Grant | A | 0.00 | 1,500 | 0 | 6,832 | 5.3 K to 6.8 K (+28.13 %) | |
Jun 22 2020 | BLUE | bluebird bio, Inc. | Schenkein David P | Grant | A | 0.00 | 156 | 0 | 5,332 | 5.2 K to 5.3 K (+3.01 %) | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | A | 0.00 | 3,253 | 0 | 3,253 | |
Jun 05 2020 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | A | 28.82 | 15,183 | 437,574 | 15,183 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | A | 0.00 | 1,686 | 0 | 1,686 | |
Jun 01 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | A | 53.35 | 8,096 | 431,922 | 8,096 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 2,775 | 0 | 5,549 | |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 48.66 | 880 | 42,821 | 105,053 | 105.9 K to 105.1 K (-0.83 %) |
Feb 25 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 2,775 | 0 | 105,933 | 103.2 K to 105.9 K (+2.69 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 8,125 | 0 | 8,125 | |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 52.01 | 2,534 | 131,793 | 103,158 | 105.7 K to 103.2 K (-2.40 %) |
Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 8,125 | 0 | 105,692 | 97.6 K to 105.7 K (+8.33 %) |
Nov 15 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | P | 31.00 | 8,064 | 249,984 | 97,567 | 89.5 K to 97.6 K (+9.01 %) |
Jun 10 2019 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Option Exercise | A | 122.01 | 4,000 | 488,040 | 4,000 | |
Jun 10 2019 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Grant | A | 0.00 | 1,000 | 0 | 5,176 | 4.2 K to 5.2 K (+23.95 %) |
Jun 03 2019 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | A | 19.50 | 27,245 | 531,278 | 27,245 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | A | 0.00 | 8,324 | 0 | 8,324 | |
Feb 26 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | A | 58.86 | 45,719 | 2,691,020 | 45,719 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Option Exercise | M | 0.00 | 8,125 | 0 | 16,250 | |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Payment of Exercise | F | 58.03 | 2,471 | 143,392 | 89,503 | 92 K to 89.5 K (-2.69 %) |
Feb 20 2019 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Director | Buy | M | 0.00 | 8,125 | 0 | 91,974 | 83.8 K to 92 K (+9.69 %) |
Nov 19 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Gift | G | 0.00 | 1,000 | 0 | 270,772 | 271.8 K to 270.8 K (-0.37 %) |
Sep 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 31.64 | 8,730 | 276,217 | 137,471 | |
Sep 12 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 31.64 | 8,730 | 276,217 | 83,849 | 75.1 K to 83.8 K (+11.62 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 31.64 | 2,500 | 79,100 | 146,201 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 2.34 | 72,619 | 169,928 | 0 | |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 31.64 | 2,500 | 79,100 | 75,119 | 72.6 K to 75.1 K (+3.44 %) |
Sep 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 2.34 | 72,619 | 169,928 | 72,619 | 0 to 72.6 K |
Jun 22 2018 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Option Exercise | A | 183.10 | 4,000 | 732,400 | 4,000 | |
Jun 22 2018 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Grant | A | 0.00 | 1,000 | 0 | 4,176 | 3.2 K to 4.2 K (+31.49 %) |
Jun 15 2018 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | A | 18.92 | 27,830 | 526,544 | 27,830 | |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 2.34 | 108 | 253 | 72,619 | |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.47 | 12,892 | 6,027 | 0 | |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 96.91 | 100 | 9,691 | 0 | 100 to 0 (-100.00 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 96.40 | 3,190 | 307,516 | 100 | 3.3 K to 100 (-96.96 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 95.11 | 8,200 | 779,902 | 3,290 | 11.5 K to 3.3 K (-71.37 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 94.37 | 1,510 | 142,499 | 11,490 | 13 K to 11.5 K (-11.62 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 2.34 | 108 | 253 | 13,000 | 12.9 K to 13 K (+0.84 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.47 | 12,892 | 6,027 | 12,892 | 0 to 12.9 K |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.47 | 23,471 | 10,973 | 12,892 | |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 16,193 | 4,898 | 0 | |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 5,962 | 1,804 | 0 | |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 90.07 | 45,626 | 4,109,534 | 0 | 45.6 K to 0 (-100.00 %) |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.47 | 23,471 | 10,973 | 45,626 | 22.2 K to 45.6 K (+105.94 %) |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 16,193 | 4,898 | 22,155 | 6 K to 22.2 K (+271.60 %) |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 5,962 | 1,804 | 5,962 | 0 to 6 K |
May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 49,374 | 14,936 | 16,193 | |
May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 92.03 | 299 | 27,517 | 0 | 299 to 0 (-100.00 %) |
May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 91.60 | 9,301 | 851,972 | 299 | 9.6 K to 299 (-96.89 %) |
May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 90.11 | 39,774 | 3,584,035 | 9,600 | 49.4 K to 9.6 K (-80.56 %) |
May 29 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 49,374 | 14,936 | 49,374 | 0 to 49.4 K |
May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,000 | 3,933 | 65,567 | |
May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 84.35 | 100 | 8,435 | 0 | 100 to 0 (-100.00 %) |
May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 83.56 | 2,814 | 235,138 | 100 | 2.9 K to 100 (-96.57 %) |
May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 82.88 | 10,086 | 835,928 | 2,914 | 13 K to 2.9 K (-77.58 %) |
May 03 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,000 | 3,933 | 13,000 | 0 to 13 K |
Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,000 | 3,933 | 78,567 | |
Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 79.49 | 2,113 | 167,962 | 0 | 2.1 K to 0 (-100.00 %) |
Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 78.59 | 3,390 | 266,420 | 2,113 | 5.5 K to 2.1 K (-61.60 %) |
Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 77.76 | 3,340 | 259,718 | 5,503 | 8.8 K to 5.5 K (-37.77 %) |
Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 76.40 | 2,600 | 198,640 | 8,843 | 11.4 K to 8.8 K (-22.72 %) |
Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 75.54 | 1,557 | 117,616 | 11,443 | 13 K to 11.4 K (-11.98 %) |
Apr 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,000 | 3,933 | 13,000 | 0 to 13 K |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 0.00 | 24,375 | 0 | 24,375 | |
Feb 20 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | A | 77.70 | 97,500 | 7,575,750 | 97,500 | |
Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,000 | 3,933 | 104,567 | |
Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 79.23 | 4,460 | 353,366 | 0 | 4.5 K to 0 (-100.00 %) |
Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 78.50 | 8,540 | 670,390 | 4,460 | 13 K to 4.5 K (-65.69 %) |
Feb 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,000 | 3,933 | 13,000 | 0 to 13 K |
Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 23,572 | 7,131 | 117,567 | |
Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 82.22 | 2,966 | 243,865 | 0 | 3 K to 0 (-100.00 %) |
Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 81.40 | 11,369 | 925,437 | 2,966 | 14.3 K to 3 K (-79.31 %) |
Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.35 | 9,237 | 742,193 | 14,335 | 23.6 K to 14.3 K (-39.19 %) |
Jan 30 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 23,572 | 7,131 | 23,572 | 0 to 23.6 K |
Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 20 | 6 | 141,139 | |
Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.01 | 20 | 1,600 | 0 | 20 to 0 (-100.00 %) |
Jan 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 20 | 6 | 20 | 0 to 20 |
Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 13,533 | 4,094 | 141,159 | |
Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 32,875 | 9,945 | 5,962 | |
Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.01 | 13,533 | 1,082,775 | 0 | 13.5 K to 0 (-100.00 %) |
Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 13,533 | 4,094 | 13,533 | 0 to 13.5 K |
Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 80.01 | 32,875 | 2,630,329 | 0 | 32.9 K to 0 (-100.00 %) |
Jan 25 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 32,875 | 9,945 | 32,875 | 0 to 32.9 K |
Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 53,000 | 16,033 | 154,692 | |
Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 74.80 | 6,597 | 493,456 | 0 | 6.6 K to 0 (-100.00 %) |
Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 74.11 | 10,914 | 808,837 | 6,597 | 17.5 K to 6.6 K (-62.33 %) |
Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 73.02 | 22,304 | 1,628,638 | 17,511 | 39.8 K to 17.5 K (-56.02 %) |
Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 71.77 | 13,185 | 946,287 | 39,815 | 53 K to 39.8 K (-24.88 %) |
Jan 16 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 53,000 | 16,033 | 53,000 | 0 to 53 K |
Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | C | 0.00 | 19,774 | 0 | 0 | |
Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | C | 0.00 | 105,225 | 0 | 0 | |
Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | C | 0.00 | 19,774 | 0 | 0 | |
Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | C | 0.00 | 105,225 | 0 | 0 | |
Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Buy | C | 0.00 | 19,774 | 0 | 19,774 | 0 to 19.8 K |
Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Buy | C | 0.00 | 105,225 | 0 | 105,225 | 0 to 105.2 K |
Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Buy | C | 0.00 | 19,774 | 0 | 19,774 | 0 to 19.8 K |
Dec 12 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Buy | C | 0.00 | 105,225 | 0 | 105,225 | 0 to 105.2 K |
Dec 08 2017 | DNLI | Denali Therapeutic ... | Schenkein David P | Director | Option Exercise | A | 18.00 | 47,165 | 848,970 | 47,165 | |
Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 26,656 | |
Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 63.32 | 4,260 | 269,743 | 0 | 4.3 K to 0 (-100.00 %) |
Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 64.64 | 942 | 60,891 | 4,260 | 5.2 K to 4.3 K (-18.11 %) |
Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 65.42 | 598 | 39,121 | 5,202 | 5.8 K to 5.2 K (-10.31 %) |
Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 66.75 | 200 | 13,350 | 5,800 | 6 K to 5.8 K (-3.33 %) |
Nov 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |
Oct 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 80,000 | 24,200 | 32,656 | |
Oct 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 70.14 | 80,000 | 5,611,200 | 0 | 80 K to 0 (-100.00 %) |
Oct 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 80,000 | 24,200 | 80,000 | 0 to 80 K |
Oct 04 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 112,656 | |
Oct 04 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 66.76 | 6,000 | 400,560 | 0 | 6 K to 0 (-100.00 %) |
Oct 04 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |
Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 35,000 | 10,588 | 118,656 | |
Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 67.12 | 35,000 | 2,349,200 | 0 | 35 K to 0 (-100.00 %) |
Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 35,000 | 10,588 | 35,000 | 0 to 35 K |
Sep 20 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Gift | G | 0.00 | 500 | 0 | 271,772 | 272.3 K to 271.8 K (-0.18 %) |
Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 6,000 | 1,815 | 153,656 | |
Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 62.20 | 6,000 | 373,200 | 0 | 6 K to 0 (-100.00 %) |
Sep 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 6,000 | 1,815 | 6,000 | 0 to 6 K |
Sep 05 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Option Exercise | M | 8.16 | 2,000 | 16,312 | 19,361 | |
Sep 05 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Sell | S | 115.07 | 2,000 | 230,145 | 3,176 | 5.2 K to 3.2 K (-38.64 %) |
Sep 05 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Buy | M | 8.16 | 2,000 | 16,312 | 5,176 | 3.2 K to 5.2 K (+62.97 %) |
Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 24,000 | 7,260 | 159,656 | |
Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 3,000 | 908 | 183,656 | |
Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 60.55 | 24,000 | 1,453,200 | 0 | 24 K to 0 (-100.00 %) |
Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 24,000 | 7,260 | 24,000 | 0 to 24 K |
Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 55.12 | 3,000 | 165,360 | 0 | 3 K to 0 (-100.00 %) |
Aug 03 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 3,000 | 908 | 3,000 | 0 to 3 K |
Jul 06 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 3,000 | 908 | 186,656 | |
Jul 06 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 51.18 | 3,000 | 153,540 | 0 | 3 K to 0 (-100.00 %) |
Jul 06 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 3,000 | 908 | 3,000 | 0 to 3 K |
Jun 12 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Option Exercise | A | 111.00 | 4,000 | 444,000 | 4,000 | |
Jun 12 2017 | BLUE | bluebird bio, Inc. | Schenkein David P | Director | Grant | A | 0.00 | 1,000 | 0 | 3,176 | 2.2 K to 3.2 K (+45.96 %) |
Jun 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 1,900 | 575 | 189,656 | |
Jun 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 1,100 | 333 | 191,556 | |
Jun 08 2017 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 50.02 | 1,900 | 95,038 | 0 | 1.9 K to 0 (-100.00 %) |